PubMed · 1006896
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
H Schatz. A modified stereo viewer.. https://pubmed.ncbi.nlm.nih.gov/1006896/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
There is no generally accepted therapy for patients with central retinal vein occlusion. Only few of the therapeutic strategies in use demonstrated their effectiveness in studies with large patient populations, others have the disadvantage of unacceptable side effects. The aim of the immediate therapy is the improvement of blood perfusion. Prognostically relevant factors like the activity of components of the blood coagulation system, rheology characteristics and predisposing vascular disease risk factors have to be considered. A risk adapted management includes the immediate anticoagulation with heparin. Haemodilution, fibrinolytic therapy and hyperbaric oxygen therapy represent other therapeutic strategies. The efficacy of new promising therapies has to be thoroughly evaluated in studies with large stratified patient populations.
BACKGROUND: The value of prophylactic photocoagulation of soft drusen is unclear. Photocoagulation is usually performed by a continuous wave laser. METHODS: We report the cases of two patients with age-related macular degeneration with soft drusen who were treated by selective retinal pigment epithelium (RPE) photocoagulation of a pulsed Nd:YLF (527 nm) laser. Laser parameters were: wavelength 527 nm, number of pulses in a train 500, pulse duration 1.7 microseconds, energy per pulse 70 microJ, spot size 160 microns, repetition rate 500 Hz. RESULTS: Dosimetry performed individually showed that in both patients laser photocoagulation was performed at the threshold of RPE disruption. None of the laser effects was visible during photocoagulation. They were detectable only by fluorescein angiography. Despite identical photocoagulation parameters the RPE reaction was completely different. In the first patient RPE hyperpigmentation was notable at most photocoagulation sites and the drusen had disappeared after 6 months. In the second patient the laser effects were not visible after 6 months by biomicroscopy and the drusen stayed unchanged. CONCLUSION: These findings could reflect different repair mechanisms of the RPE after alteration and could represent a sign of a different viable stage in the life of RPE cells. Close attention should be paid to this phenomenon in the various drusen studies currently under way.